ArticleClinical cancer research : an official journal of the American Association for Cancer Research2012

A phase I dose-finding trial of recombinant interleukin-21 and rituximab in relapsed and refractory low grade B-cell lymphoproliferative disorders.

John M Timmerman et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.